Osaka, Japan

Michiko Tajiri


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Introduction

Michiko Tajiri is an accomplished inventor based in Osaka, Japan, known for her significant contributions to the field of medical research. With a focus on developing innovative therapeutic agents, she has worked diligently to address diseases linked to abnormalities in dystroglycan glycosylation. Her pioneering work is encapsulated in her sole patent, which showcases her dedication to advancing healthcare solutions.

Latest Patents

Michiko Tajiri holds one notable patent titled "Therapeutic agent for diseases associated with abnormalities in dystroglycan sugar chain modification and method for assaying associated enzyme." This patent addresses a therapeutic agent that effectively acts on diseases caused by abnormal glycosylation of dystroglycan. Specifically, her invention provides a testing method for such diseases and highlights CDP-ribitol as the critical active ingredient. This groundbreaking discovery demonstrates how CDP-ribitol can be utilized to restore the glycan structure in ISPD-deficient cells, paving the way for new supplementation therapy approaches.

Career Highlights

Throughout her career, Michiko Tajiri has been affiliated with prestigious institutions such as Kobe University and Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology. Her roles in these organizations have allowed her to collaborate with prominent experts in her field, further enhancing her research and impact on healthcare.

Collaborations

Michiko has worked alongside talented colleagues, including Tatsushi Toda and Kazuhiro Kobayashi. These collaborations have enriched her projects and contributed to the successful development of her patent, demonstrating the power of teamwork in scientific research and innovation.

Conclusion

In conclusion, Michiko Tajiri's innovative work in the realm of therapeutic agents marks her as a significant inventor in her field. Her patent addressing abnormalities in dystroglycan glycosylation highlights her commitment to improving patient care and delivering novel solutions to complex health challenges. As her career progresses, her contributions are sure to resonate in the healthcare community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…